Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound ... a head-to-head contest with the latter's Wegovy (semaglutide) brand. Both companies have been ...

1 Lilly also reduced the price of the 2.5 mg and 5 mg vials. These new offerings are available exclusively through LillyDirect Self Pay Pharmacy Solutions, which enables a transparent price by ...

This comprehensive review explores MEDVi, a leading telehealth provider offering compounded GLP-1 weight loss solutions like Semaglutide and Tirzepatide in both injection and tablet form. The article ...

Adult patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate or advanced liver fibrosis showed improved liver histology with a once-weekly dose of semaglutide (Wegovy ...

Semaglutide shows promise in MASH treatment, achieving significant MASH resolution and fibrosis improvement in the ESSENCE trial. Tolerability issues and insurance coverage challenges lead to 20% ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 ...

Universities have “lost sight” of their responsibility concerning public money and should be more transparent about how it is spent, a Government minister has said (PA) Universities have ...

With numerous commitments made in VPAG, time will tell how transparent the government’s agencies and industry will be about progress and delivery, but there are reasons to be optimistic.

Is the Zepbound vial cheaper than the pen form? Possibly. Your price of Zepbound may depend on several factors, including the form you’re prescribed. Zepbound comes in two forms: single-dose ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review the ...

Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on Thursday, May 8, 2025. (AP Photo/JoNel Aleccia) ...